Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00542308 · ClinicalTrials.gov registry record · Phase 2
Zalutumumab in Non-curable Patients With SCCHN
A Phase 2 study, sponsored by Genmab.
- Completed
- Registry status
- Phase 2
- Development phase
- 90
- Enrollment target
NCT00542308 is a Phase 2 study that has completed, run by Genmab. The registered enrollment target is 90 participants.
The verdict
NCT00542308, a Phase 2 study, has completed, sponsored by Genmab.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 90 participants
- Enrollment target
Study Summary
Treatment, In combination with BSC, Open-label, Single arm, Efficacy Study.
Interventions
- DRUG Zalutumumab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2008-01 |
| Est. Completion | 2011-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00542308
The ClinicalTrials.gov registry entry for NCT00542308 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Genmab, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zalutumumab is the first listed.
NCT00542308 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00542308 about?
NCT00542308 is a clinical study titled "Zalutumumab in Non-curable Patients With SCCHN". Treatment, In combination with BSC, Open-label, Single arm, Efficacy Study.
What is the current status of trial NCT00542308?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 90 participants. The study started on 2008-01. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00542308?
The interventions under investigation include: Zalutumumab (DRUG).
Who is sponsoring clinical trial NCT00542308?
This trial is sponsored by Genmab, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.